Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Inventory (2023 - 2024)

Roivant Sciences (ROIV) has disclosed Inventory for 2 consecutive years, with $34.0 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Inventory rose 704.66% year-over-year to $34.0 million, compared with a TTM value of $34.0 million through Jun 2024, up 704.66%, and an annual FY2024 reading of $35.3 million, up 1176.75% over the prior year.
  • Inventory was $34.0 million for Q2 2024 at Roivant Sciences, down from $35.3 million in the prior quarter.
  • Across five years, Inventory topped out at $35.3 million in Q1 2024 and bottomed at $2.8 million in Q1 2023.